181 related articles for article (PubMed ID: 10871980)
1. Use of calcium channel blockers and risk of hospitalized gastrointestinal tract bleeding.
Kaplan RC; Heckbert SR; Koepsell TD; Rosendaal FR; Psaty BM
Arch Intern Med; 2000 Jun; 160(12):1849-55. PubMed ID: 10871980
[TBL] [Abstract][Full Text] [Related]
2. Risk of hospitalization for upper gastrointestinal tract bleeding associated with ketorolac, other nonsteroidal anti-inflammatory drugs, calcium antagonists, and other antihypertensive drugs.
García Rodríguez LA; Cattaruzzi C; Troncon MG; Agostinis L
Arch Intern Med; 1998 Jan; 158(1):33-9. PubMed ID: 9437376
[TBL] [Abstract][Full Text] [Related]
3. Risk of hospitalized gastrointestinal bleeding in persons randomized to diuretic, ACE-inhibitor, or calcium-channel blocker in ALLHAT.
Phillips W; Piller LB; Williamson JD; Whittle J; Jafri SZ; Ford CE; Einhorn PT; Oparil S; Furberg CD; Grimm RH; Alderman MH; Davis BR; Probstfield JL;
J Clin Hypertens (Greenwich); 2013 Nov; 15(11):825-32. PubMed ID: 24283598
[TBL] [Abstract][Full Text] [Related]
4. Antihypertensive drugs and the risk of gastrointestinal bleeding.
Suissa S; Bourgault C; Barkun A; Sheehy O; Ernst P
Am J Med; 1998 Sep; 105(3):230-5. PubMed ID: 9753026
[TBL] [Abstract][Full Text] [Related]
5. Risk of hospitalized and non-hospitalized gastrointestinal bleeding in ALLHAT trial participants receiving diuretic, ACE-inhibitor, or calcium-channel blocker.
Du XL; Simpson LM; Tandy BC; Bettencourt JL; Davis BR
PLoS One; 2021; 16(11):e0260107. PubMed ID: 34793552
[TBL] [Abstract][Full Text] [Related]
6. Antihypertensive drug therapies and the risk of ischemic stroke.
Klungel OH; Heckbert SR; Longstreth WT; Furberg CD; Kaplan RC; Smith NL; Lemaitre RN; Leufkens HG; de Boer A; Psaty BM
Arch Intern Med; 2001 Jan; 161(1):37-43. PubMed ID: 11146696
[TBL] [Abstract][Full Text] [Related]
7. No association between calcium channel blocker use and confirmed bleeding peptic ulcer disease.
Smalley WE; Ray WA; Daugherty JR; Griffin MR
Am J Epidemiol; 1998 Aug; 148(4):350-4. PubMed ID: 9717878
[TBL] [Abstract][Full Text] [Related]
8. Effects of Long- and Intermediate-Acting Dihydropyridine Calcium Channel Blockers in Hypertension: A Systematic Review and Meta-Analysis of 18 Prospective, Randomized, Actively Controlled Trials.
Chaugai S; Sherpa LY; Sepehry AA; Kerman SRJ; Arima H
J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):433-445. PubMed ID: 29739234
[TBL] [Abstract][Full Text] [Related]
9. Risk of gastrointestinal haemorrhage with calcium antagonists in hypertensive persons over 67 years old.
Pahor M; Guralnik JM; Furberg CD; Carbonin P; Havlik R
Lancet; 1996 Apr; 347(9008):1061-5. PubMed ID: 8602055
[TBL] [Abstract][Full Text] [Related]
10. Antihypertensive drugs and fatal myocardial infarction in persons with uncomplicated hypertension.
Jick H; Vasilakis C; Derby LE
Epidemiology; 1997 Jul; 8(4):446-8. PubMed ID: 9209862
[TBL] [Abstract][Full Text] [Related]
11. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
[TBL] [Abstract][Full Text] [Related]
12. The risk of myocardial infarction associated with antihypertensive drug therapies.
Psaty BM; Heckbert SR; Koepsell TD; Siscovick DS; Raghunathan TE; Weiss NS; Rosendaal FR; Lemaitre RN; Smith NL; Wahl PW
JAMA; 1995 Aug 23-30; 274(8):620-5. PubMed ID: 7637142
[TBL] [Abstract][Full Text] [Related]
13. Antihypertensive medications and risk of community-acquired pneumonia.
Mukamal KJ; Ghimire S; Pandey R; O'Meara ES; Gautam S
J Hypertens; 2010 Feb; 28(2):401-5. PubMed ID: 20051911
[TBL] [Abstract][Full Text] [Related]
14. Potentially Inappropriate Antihypertensive Prescriptions to Elderly Patients: Results of a Prospective, Observational Study.
Márquez PHP; Torres OH; San-José A; Vidal X; Agustí A; Formiga F; López-Soto A; Ramírez-Duque N; Fernández-Moyano A; Garcia-Moreno J; Arroyo JA; Ruiz D;
Drugs Aging; 2017 Jun; 34(6):453-466. PubMed ID: 28432600
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological interventions for hypertension in children.
Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
[TBL] [Abstract][Full Text] [Related]
16. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis.
Psaty BM; Smith NL; Siscovick DS; Koepsell TD; Weiss NS; Heckbert SR; Lemaitre RN; Wagner EH; Furberg CD
JAMA; 1997 Mar; 277(9):739-45. PubMed ID: 9042847
[TBL] [Abstract][Full Text] [Related]
17. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis.
Lee S; Hess EP; Nestler DM; Bellamkonda Athmaram VR; Bellolio MF; Decker WW; Li JT; Hagan JB; Manivannan V; Vukov SC; Campbell RL
J Allergy Clin Immunol; 2013 Apr; 131(4):1103-8. PubMed ID: 23453138
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hospitalized upper or lower gastrointestinal tract bleeding in treated hypertensives.
Kaplan RC; Heckbert SR; Psaty BM
Prev Med; 2002 Apr; 34(4):455-62. PubMed ID: 11914052
[TBL] [Abstract][Full Text] [Related]
19. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
Wassertheil-Smoller S; Psaty B; Greenland P; Oberman A; Kotchen T; Mouton C; Black H; Aragaki A; Trevisan M
JAMA; 2004 Dec; 292(23):2849-59. PubMed ID: 15598916
[TBL] [Abstract][Full Text] [Related]
20. Beta-blockers for hypertension.
Wiysonge CS; Bradley H; Mayosi BM; Maroney R; Mbewu A; Opie LH; Volmink J
Cochrane Database Syst Rev; 2007 Jan; (1):CD002003. PubMed ID: 17253471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
